Suppliers / Wealphar Pharmaceutical Joint Stock

Wealphar Pharmaceutical Joint Stock

Vietnam Updated 9 July 2026

Wealphar Pharmaceutical Joint Stock is an API and finished-dose manufacturer based in Vietnam. It appears in 294 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
294
filings across 1 regulators

What they file, and where

Molecule Regulators Docs
Ramipril DAV (Vietnam) 3
Valsartan DAV (Vietnam) 3
Carbocisteine DAV (Vietnam) 2
Etodolac DAV (Vietnam) 2
Haloperidol DAV (Vietnam) 2
Ketoprofen DAV (Vietnam) 2
L-Ornithin L-Aspartat DAV (Vietnam) 2
Metronidazole DAV (Vietnam) 2
Naproxen DAV (Vietnam) 2
Pravastatin DAV (Vietnam) 2
Show all 30 molecules on file
Rosuvastatin DAV (Vietnam) 2
Acetylsalicylic Acid DAV (Vietnam) 1
Bisoprolol DAV (Vietnam) 1
Captopril DAV (Vietnam) 1
Cetirizine DAV (Vietnam) 1
Cimetidine DAV (Vietnam) 1
Dexibuprofen DAV (Vietnam) 1
Dexlansoprazole DAV (Vietnam) 1
Donepezil DAV (Vietnam) 1
Doxazosin DAV (Vietnam) 1
Ebastine DAV (Vietnam) 1
Ferrous DAV (Vietnam) 1
Fexofenadine DAV (Vietnam) 1
Fluvoxamine DAV (Vietnam) 1
Hydroclorothiazide DAV (Vietnam) 1
Ibuprofen DAV (Vietnam) 1
Irbesartan DAV (Vietnam) 1
Isoleucine DAV (Vietnam) 1
Lovastatin DAV (Vietnam) 1
Mequitazine DAV (Vietnam) 1

Also appears on these molecule pages

Acetylsalicylic Acid API Captopril API Carbocisteine API Cimetidine API Dexibuprofen API Dexlansoprazole API Doxazosin API Ebastine API Etodolac API Ferrous API Fluvastatin finished dose Fluvoxamine API
Show 25 more molecule pages
Haloperidol API Hydroclorothiazide API Isoleucine API Ketoprofen API L-Ornithin L-Aspartat API Lovastatin API Metronidazole API Naproxen API Nizatidine API Piroxicam API Pravastatin API Propylthiouracil finished dose Ramipril API Rebamipid finished dose Sucralfate API Sulpiride API Zopiclone API Ibuprofen API Valsartan API Rosuvastatin API Bisoprolol API Cetirizine API Fexofenadine API Irbesartan API Donepezil API

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 294 None

Questions about Wealphar Pharmaceutical Joint Stock

Does Wealphar Pharmaceutical Joint Stock hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Wealphar Pharmaceutical Joint Stock. It does have 294 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
What does Wealphar Pharmaceutical Joint Stock make?
30 molecules are on record against Wealphar Pharmaceutical Joint Stock, including Ramipril, Valsartan, Carbocisteine and Etodolac. Each links through to that molecule's full manufacturer list.
Where does Wealphar Pharmaceutical Joint Stock file?
Filings are on record with DAV (Vietnam), 294 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Wealphar Pharmaceutical Joint Stock comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Dr Reddy's Laboratories shares 5 molecules Apotex shares 5 molecules Imexpharm shares 5 molecules Apitoria Pharma shares 3 molecules Hetero shares 3 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability